INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 449m ago
HOUSE PTR48m ago
SEC 13F48m ago
ROBINHOOD CHAIN48m ago
FP
Corporate insider

Foster Jonathan P.

Chief Financial OfficerCIK 0001545414

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
41 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Moleculin Biotech, Inc.Chief Financial Officer · Nov 6, 2026
9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Tax withholding
F
$84.6
10 sh
Nov 4, 2026
Nov 6, 2026
traded Nov 4, 2026
+2d
SEC FORM 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
41 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence